101 reports of this reaction
1.5% of all CAPSAICIN reports
#9 most reported adverse reaction
INSOMNIA is the #9 most commonly reported adverse reaction for CAPSAICIN, manufactured by Averitas Pharma Inc. There are 101 FDA adverse event reports linking CAPSAICIN to INSOMNIA. This represents approximately 1.5% of all 6,703 adverse event reports for this drug.
Patients taking CAPSAICIN who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INSOMNIA is a less commonly reported adverse event for CAPSAICIN, but still significant enough to appear in the safety profile.
In addition to insomnia, the following adverse reactions have been reported for CAPSAICIN:
The following drugs have also been linked to insomnia in FDA adverse event reports:
INSOMNIA has been reported as an adverse event in 101 FDA reports for CAPSAICIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
INSOMNIA accounts for approximately 1.5% of all adverse event reports for CAPSAICIN, making it a notable side effect.
If you experience insomnia while taking CAPSAICIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.